146 related articles for article (PubMed ID: 20682662)
1. Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
Martens HA; Gross S; van der Steege G; Brouwer E; Berden JH; de Sevaux R; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Kallenberg CG; Bijl M
J Rheumatol; 2010 Nov; 37(11):2226-31. PubMed ID: 20682662
[TBL] [Abstract][Full Text] [Related]
2. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5.
Gómez-Reino JJ; Pablos JL; Carreira PE; Santiago B; Serrano L; Vicario JL; Balsa A; Figueroa M; de Juan MD
Arthritis Rheum; 1999 May; 42(5):989-92. PubMed ID: 10323455
[TBL] [Abstract][Full Text] [Related]
3. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
[TBL] [Abstract][Full Text] [Related]
4. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
[TBL] [Abstract][Full Text] [Related]
5. Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism -169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis.
Chen JY; Wang CM; Wu YJ; Kuo SN; Shiu CF; Chang SW; Lin YT; Ho HH; Wu J
J Rheumatol; 2011 Feb; 38(2):264-70. PubMed ID: 21078711
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.
Aguilar F; Núñez-Roldán A; Torres B; Wichmann I; Sánchez-Román J; González-Escribano MF
J Rheumatol; 2003 Aug; 30(8):1770-4. PubMed ID: 12913933
[TBL] [Abstract][Full Text] [Related]
7. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
Zhou TB; Jiang ZP; Zhou JF; Su N
Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
[TBL] [Abstract][Full Text] [Related]
8. CCR5-Delta32: implications in SLE development.
Carvalho C; Calvisi SL; Leal B; Bettencourt A; Marinho A; Almeida I; Farinha F; Costa PP; Silva BM; Vasconcelos C
Int J Immunogenet; 2014 Jun; 41(3):236-41. PubMed ID: 24164722
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan.
Pan CF; Wu CJ; Chen HH; Dang CW; Chang FM; Liu HF; Chu CC; Lin M; Lee YJ
Lupus; 2009 Jul; 18(8):698-704. PubMed ID: 19502265
[TBL] [Abstract][Full Text] [Related]
10. The delta32 deletion of CCR5 receptor in rheumatoid arthritis.
Cooke SP; Forrest G; Venables PJ; Hajeer A
Arthritis Rheum; 1998 Jun; 41(6):1135-6. PubMed ID: 9627027
[No Abstract] [Full Text] [Related]
11. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
[TBL] [Abstract][Full Text] [Related]
12. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
[TBL] [Abstract][Full Text] [Related]
13. Role of CCR5 Delta32 bp deletion in RA and SLE.
Martens HA; Kallenberg CG; Bijl M
Autoimmunity; 2009 May; 42(4):260-2. PubMed ID: 19811270
[TBL] [Abstract][Full Text] [Related]
14. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis.
Malafronte P; Vieira JM; Pereira AC; Krieger JE; Barros RT; Woronik V
J Rheumatol; 2010 Apr; 37(4):776-82. PubMed ID: 20231199
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.
Martens HA; Nienhuis HL; Gross S; van der Steege G; Brouwer E; Berden JH; de Sévaux RG; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Nolte IM; Kallenberg CG; Bijl M
Lupus; 2012 Aug; 21(9):959-68. PubMed ID: 22513366
[TBL] [Abstract][Full Text] [Related]
16. Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population.
Vazgiourakis V; Sidiropoulos P; Bertsias G; Koutsounaki E; Fragouli E; Raptopoulou A; Kritikos H; Boumpas DT; Goulielmos GN
Lupus; 2007; 16(11):867-74. PubMed ID: 17971359
[TBL] [Abstract][Full Text] [Related]
17. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
[TBL] [Abstract][Full Text] [Related]
19. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.
Scheibel I; Veit T; Neves AG; Souza L; Prezzi S; Machado S; Kohem C; Icarelli M; Xavier R; Brenol JC; Chies JA
Scand J Rheumatol; 2008; 37(1):13-7. PubMed ID: 18189189
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus.
Hur JW; Sung YK; Shin HD; Park BL; Cheong HS; Bae SC
Rheumatology (Oxford); 2006 Jun; 45(6):711-7. PubMed ID: 16461442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
